Top Headlines

EMEA view of atypical actives is a ‘pragmatic’ solution

Manufacturers of ingredients used as excipients in pharmaceuticals have faced some regulatory problems with a series substances known as 'atypical actives'.

Related news

Authorities seek injunction against Actavis in US

The US authorities are turning up the heat on Icelandic generic drugmaker Actavis over manufacturing problems at the New Jersey plant which makes its recalled Digitek brand of the cardiac drug digoxin.

DSM agrees to Deretil management buyout

DSM Deretil, the chemical side-chain manufacturing operation of DSM's anti-infectives unit, is to go it alone through a management buyout.

PharmaForm's EPAS aims to make particle processing less of a grind

PharmaForm's new EPAS particle engineering technology, launched at this year's AAPS in Atlanta, US, may help drugmakers improve the solubility of insoluble actives without some of the costly and time consuming processing steps used by traditional methods.

UK report calls for nano regulations

The UK Royal Commission has issued a report on the spread of nanomaterials, stating that “urgent action [is] needed on testing and regulation”.

News in brief

Today's headlines across the Pharmaceutical industry

etrials sees losses escalate; names new CEO from OutSourcingPharma

eClinical specialist etrials Worldwide saw its losses quadruple in the third quarter on the back of a dip in revenues and financial charges, including a $4m asset impairment charge related to goodwill.

Poland set to remove tax block for clinical trials from OutSourcingPharma

One of the obstacles to the development of Poland’s clinical research market is due to be removed next month, according to local consultancy firm Polish Market Research.

Adolescents are under-represented in clinical research from OutSourcingPharma

Recent European legislation designed to increase the number of children in clinical trials has had a positive impact in ensuring that paediatric patients are included in medicine testing.

Smithers sets up formulation unit from OutSourcingPharma

US company Smithers Group has launched a formulation services company to tap into the emerging trend towards outsourcing of drug development among pharmaceutical companies.

On your radar